Study record · Omberacetam (Noopept)
Clinical and EEG characteristics of Noopept in mild cognitive impairment of vascular or traumatic origin
Noopept was associated with increased alpha/beta and reduced delta EEG power, interpreted as nonspecific activation/anxiolytic-type changes.
Key result
Noopept was associated with increased alpha/beta and reduced delta EEG power, interpreted as nonspecific activation/anxiolytic-type changes.
Study details
Study designClinical study with EEG outcomes
PopulationPatients with cognitive disturbances after vascular or traumatic brain disease
Sample sizeNot stated in abstract
RouteOral
Regimen / exposureClinical Noopept treatment; exact regimen not reproduced in the abstract
DurationClinical course
ComparatorNo placebo control described in abstract
Primary endpoint / questionEEG rhythm changes and cognitive/asthenic clinical context
Safety resultContemporary safety characterization was limited.
Key limitationsRussian-language study; no placebo-controlled blinded design established from the abstract.
Registry / identifierPMID 19008801